Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS17P2 is a processed pseudogene located on chromosome 5q23.1[5]. It shares high sequence similarity with the functional ribosomal protein S17 gene (RPS17)[5], but, as a pseudogene, it does not encode a functional protein product and is not involved in ribosome function. Like most ribosomal protein pseudogenes, RPS17P2 arose via retrotransposition and does not perform a known biological function, nor is it associated with any disease roles or therapeutic interventions[8][5]. As such, it is not a drug target, a functional biomarker, or implicated in human disease. RPS17P2 is not a protein-coding gene but a pseudogene; it does not produce a biologically active target and has no reported role in disease, detectable phenotype, or response to drugs[5][8]. Its parent gene, RPS17, encodes a component of the 40S ribosomal subunit, but this is not true of the pseudogene[1][5]. No drugs, mechanisms, or biomarker functions are associated with RPS17P2. RPS17P2 is a non-functional pseudogene with no known biological activity, disease association, or drug interactions, and should not be considered a therapeutically relevant molecular target[5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S17 pseudogene 2 (RPS17P2).